According to Hedley Rees, Managing Consultant at health care consultancy PharmaFlow, medicines are the single biggest intervention in health care today, yet half of them are not taken as directed. The average medicine costs more than £2 billion to develop, due largely to the cost of failed trials. Taking place at Techniquest in Cardiff, UK on May 8, 2019, the MEDICINES FOR THE 21st CENTURY: Safer, Better, Cheaper conference will bring together health care professionals and patient advocates, supported by a panel of expert specialists, to examine ways of countering this massive waste of time, money and resources in the pharmaceutical industry. The Techniquest team has extensive experience in designing and running interactive learning events in science, technology, engineering and mathematics. The group will draw up a vision of the future, based on principles proven to be successful in a range of other industry sectors, where “the customer is king”. The supporting panel of specialist experts will help attendees address issues such as declining levels of innovation, productivity, and most importantly, reduced focus on delivering value for the end-users of medicines ie patients and health care professionals.
For further information on the event visit www.pharmaflowltd.com
Latest from Tom Mulligan
- EVENT PREVIEW: CPhI North America opens next week!
- NEW BUSINESS: SK biotek and AMPAC Fine Chemicals have ambitious CDMO plans
- NEW TECHNOLOGY: Polyplus-transfection develops GMP-grade therapeutic virus reagent
- Mogrify raises $3.7 million seed funding to support direct cellular conversion for cell therapy
- Owlstone Medical partners with Shanghai Renji Hospital to pioneer Breath Biopsy lung cancer trial
- Chemspace and LabNetwork collaborate to extend access to chemical databases
- TECHNOLOGY UPDATE: Catalent invests over $27 million to commercialise next-generation ODT Zydis Ultra
- SGS reports successful Phase 2 results for novel influenza vaccine, validating its H3N2 A/Belgium challenge agent
- NEW TECHNOLOGY: Horizon Discovery and Rutgers University develop new gene editing approach: ‘base editing’
- EVENT REVIEW: Busy sessions at BIO-Europe Spring!